Black pepper

Black Pepper (Piper nigrum L.): A Comprehensive Reference

1. Identity and Botanical Profile

1.1 Nomenclature and Taxonomy

Piper nigrum L., commonly known as black pepper, is a globally recognized spice with a long history of traditional medicinal use and a growing body of scientific research supporting its pharmacological potential. It belongs to the family Piperaceae. The plant is a flowering vine native to the tropical regions of South India and parts of Southeast Asia. Black pepper is frequently called the "King of Spices."

Piper nigrum is a perennial vine that can reach heights of 10 meters or more if left unchecked. It has dark green, heart-shaped leaves and small white flowers. The berries grow in clusters and start off green before ripening into red. Once dried, they shrivel into the black, wrinkled peppercorns familiar to all of us.

Today, India remains one of the largest producers of black pepper, although Vietnam and Indonesia are also leading cultivators.

1.2 Common Forms and Preparations

Black pepper, white pepper, and green pepper all originate from the same plant but are processed differently. Black pepper is made from the plant's unripened green drupes (stone fruit), which are called "peppercorns." They are briefly boiled and dried or cooked. Black pepper is made by cooking the dried unripe fruit, while white pepper is made by cooking and drying the ripe seeds.

The major commercial and supplemental preparations include:

• Whole peppercorns: Dried fruits of the vine used as a culinary spice worldwide.
• Ground black pepper: Milled peppercorns used directly as seasoning.
• Black pepper essential oil (BPEO): A natural essential oil obtained from Piper nigrum, traditionally distilled from the dried, nearly ripe fruits of the pepper vine. Its scent is warm, woody, dry, and spicy, with a fresh, aromatic lift and zero pungency, as its piquant compounds (e.g., piperine) are non-volatile and absent from the distilled oil.
• Black pepper oleoresin: A semi-solid extract containing both volatile and non-volatile compounds, including concentrated piperine, used in food technology and nutraceutical manufacturing.
• Isolated piperine: Compared to the use of pepper for food seasoning, piperine is used in food supplements in an isolated, concentrated form and ingested as a bolus.

Black pepper contains approximately 5–9% piperine and is listed by the FDA as an herb which is generally recognized as safe (GRAS) for its intended use as spice, seasoning, or flavoring.

2. Historical and Traditional Use

2.1 Ancient Trade and Economic History

Black pepper was one of the most sought-after commodities during the spice trade era, from around 1,000 BCE to 1,000 CE, and was worth its weight in gold. The spice routes, which connected the East and the West, were established primarily to facilitate the trade of black pepper and other spices. Black pepper's use in Indian cooking dates to the first century BC, and it became popular across Europe during the Roman Empire. In ancient Greece, it was so valued that it was used as currency.

2.2 Ayurvedic Tradition

In Ayurvedic practice, black pepper's medicinal use is documented in classical texts like the Charaka Samhita and Sushruta Samhita, where it is praised for treating respiratory disorders, digestive issues, and even as a rejuvenative when combined with honey. In Ayurveda, the plant is referred to as Maricha (Sanskrit), and its use extends across thousands of years. In ancient India, Maricha wasn't just a kitchen staple—it was revered in religious ceremonies and traditional healing.

Along with long pepper and ginger, black pepper forms the herbal preparation called trikatu, an important ingredient in many Ayurvedic formulations. It is also a digestive stimulant and component of trikatu, and used in Rasashastra for medicinal pill preparation. It is considered excellent for pacifying Kapha, helps pacify Vata, and increases Pitta — referring to the three doshas of Ayurvedic constitutional theory. Approximately two-thirds of all traditional Ayurvedic formulations are said to include black pepper, leveraging its reputed bioenhancing properties.

2.3 Traditional Chinese Medicine

Pepper has been used for the treatment of epilepsy since the Tang Dynasty in China. In the 1970s, Beijing Medical College developed a new drug later called "Ilepcimide," an analogue of piperine whose cinnamon amides were substituted by an aromatic ring, and which served as an antiepileptic with low toxicity. This historical use informed modern pharmacological interest in piperine derivatives for neurological conditions.

2.4 Traditional Uses in Other Cultures

Black pepper was used traditionally for the treatment of various diseases including cough, cold, dyspnea, throat diseases, intermittent fever, dysentery, stomachache, worms, and piles. In Buddhism, black pepper is identified as a key ingredient in a medicinal remedy. Ancient Greek and Roman physicians incorporated it into their materia medica, and it was a consistent feature of medieval European pharmacy.

3. Phytochemistry: Key Constituents and Active Compounds

3.1 Alkaloids

The major bioactive compound identified in P. nigrum is piperine, although other compounds are also present including piperic acid, piperlonguminine, pellitorine, piperolein B, piperamide, piperettine, and (−)-kusunokinin, which also showed biological potency.

Piperine is an alkaloid compound responsible for the distinct flavor characteristics observed in several pepper species. Piperine content varies from 2% to 9% in Piper nigrum L. based on ecologic factors such as climate and/or provenance, as well as the growing environment. The amount of piperine varies from 1–2% in long pepper, to 5–10% in commercial white and black peppers.

Piperine's pungent perception is due to its interaction with the human TRPV-1 (vanilloid receptor). Its chemical name has been rendered as (E,E)-1-[5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl]piperidine. Other alkaloids present in black pepper extracts include piperanine, piperettine, piperylin A, piperolein B, and pipericine.

3.2 Essential Oil Composition

The major components of black pepper essential oils are α-pinene, sabinene, β-pinene, δ-3-carene, limonene, and β-caryophyllene. The main oxygenated terpenes present in the essential oil of black pepper are caryophyllene oxide, linalool, terpinen-4-ol, and eugenol. The percentage of components varies widely depending on the origin and variety of the raw material, its stage of maturity, as well as the duration and conditions of storage.

The most abundant compounds in pepper oils were (E)-beta-caryophyllene (1.4–70.4%), limonene (2.9–38.4%), beta-pinene (0.7–25.6%), Δ-3-carene (1.7–19.0%), sabinene (0–12.2%), alpha-pinene (0.3–10.4%), eugenol (0.1–41.0%), terpinen-4-ol (0–13.2%), hedycaryol (0–9.1%), beta-eudesmol (0–9.7%), and caryophyllene oxide (0.1–7.2%).

The essential oil profile of black pepper seeds from south India is predominantly comprised of β-caryophyllene followed by limonene, sabinene, α-pinene, β-bisabolene, α-copaene, α-cadinol, α-thujene, and α-humulene. It is notable that piperine is non-volatile and absent from the steam-distilled essential oil, meaning the essential oil does not share the pungency of the whole spice.

3.3 Other Phytochemicals

Phytochemical analyses have described the main chemical constituents of black pepper, including carbohydrates, proteins, calcium, magnesium, potassium, iron, vitamin C, tannins, flavonoids, and carotenoids. The pharmacological potential of black pepper is due to the presence of metabolites like phenolic compounds, alkaloids, flavonoids, carotenoids, and terpenoids.

4. Established Mechanisms of Action

4.1 TRPV1 (Vanilloid Receptor) Activation

Piperine's pungent perception is due to its interaction with the human TRPV-1 or vanilloid receptor. Activation of TRPV1 underlies piperine's sensory effects (heat, irritation) and may contribute to its role in pain signaling and thermogenesis.

4.2 Bioavailability Enhancement via Enzyme and Transporter Inhibition

One of piperine's most pharmacologically significant and clinically documented mechanisms is its ability to enhance the bioavailability of co-administered drugs and nutrients. The molecular basis for piperine's pleiotropic activities includes its ability to regulate multiple signaling molecules such as P-glycoprotein, cytochrome P450 3A4, multidrug resistance protein 1, breast cancer resistance protein, and nuclear factor-κB, among many others.

Piperine inhibits the action of certain enzymes involved in the metabolism and transport of xenobiotics and metabolites, including CYP3A4 and P-glycoprotein. By inhibiting drug metabolism, piperine may increase the bioavailability of various compounds and alter the effectiveness of some medications.

Piperine enhances bioavailability of a number of drugs, including curcumin, increasing curcumin bioavailability by approximately 20-fold. Docking studies have established that piperine binds to curcumin, CYP3A4, P-glycoprotein, and UDP-glucuronosyltransferase (UGT), the enzyme responsible for glucuronidation. Glucuronidation is a Phase II metabolic process that tags compounds for rapid excretion. Curcumin is heavily glucuronidated in both the liver and intestine, which is the primary reason for its poor bioavailability. Piperine inhibits UGT enzymes, reducing the rate at which curcumin and other polyphenols are conjugated and eliminated.

4.3 Anti-Inflammatory Mechanisms

Piperine has been shown to have anti-inflammatory activity through the suppression of cyclooxygenase (COX)-2 gene expression and enzyme activity. Recent studies have demonstrated that piperine possesses anti-inflammatory properties elicited by the inhibition of PGE2 generation through suppression of COX-2 gene transcription and protein expression.

4.4 Antioxidant Mechanisms

Piperine contains various bioactive effects, including antibacterial activity, in addition to several physiological benefits such as immunomodulatory, hepatoprotective, antioxidant, and antimetastatic properties. Preclinical evidence suggests piperine can upregulate endogenous antioxidant enzyme systems, though robust human evidence for this mechanism remains limited.

5. Scientific Evidence by Area of Use

5.1 Bioavailability Enhancement — Strongest Human Clinical Evidence

The bioavailability-enhancing effect of piperine on co-administered substances represents the most robustly documented pharmacological property in human studies.

Curcumin: In humans, absorption of curcumin was very low when taken alone — serum levels were either undetectable or very low after a dose of 2 g. When 20 mg of piperine was combined with the curcumin, blood concentrations of curcumin were increased by 2000% from 0.25 to 1 hour post-administration. Piperine, a major constituent of black pepper extract, can enhance the oral bioavailability of curcumin by as much as 20-fold.

Carbamazepine: In a clinical study involving 12 healthy volunteers, a single dose of 200 mg carbamazepine was orally administered, with or without 10 consecutive days of piperine intake at 20 mg/day. The AUC of carbamazepine was 233 and 158 µg/mL·h, respectively. This 47% enhancement in AUC was attributed to the inhibition of CYP3A4 by piperine, as oral clearance of carbamazepine was significantly reduced by 38.9%.

Fexofenadine: In a study involving 12 healthy subjects who took a single 120-mg dose of fexofenadine before and after administration of piperine 20 mg/d for 10 days, fexofenadine AUC increased by 68%. The authors propose that piperine inhibits P-glycoprotein (PGP), thus increasing fexofenadine bioavailability.

Multiple drugs: The results of clinical studies suggest that piperine (usually in doses of 20 mg/day) can inhibit CYP3A4, CYP2C9, and PGP, resulting in moderate increases in plasma concentrations of CYP3A4 substrates (carbamazepine, midazolam, and possibly others), CYP2C9 substrates (diclofenac, phenytoin, and possibly warfarin and others), and PGP substrates (fexofenadine and possibly digoxin and others).

Other nutrients: Piperine is a bioavailability enhancer, which can increase bioavailability when used in combination with rifampicin, phenytoin sodium, verapamil, and others, by preventing drug efflux from cells or reducing the metabolism of drugs.

Evidence strength: This area has the strongest human clinical evidence, with multiple controlled pharmacokinetic studies confirming the bioavailability-enhancing effect across diverse compounds. The mechanism via CYP3A4 inhibition, P-gp inhibition, and UGT suppression is well-characterized.

5.2 Liver Health / Hepatoprotective Effects

Piperine, the bioactive ingredient of black pepper, can exert a significant function in treatment of individuals with NAFLD and early cirrhosis. A double-blind, randomized study investigated the impact of piperine consumption over 12 weeks on patients with NAFLD and early cirrhosis, compared to placebo. They were prescribed a placebo and 5 mg of piperine for 12 weeks, respectively. Piperine with a daily dosage of 5 mg could significantly decrease hepatic enzymes and glucose, and alleviate dyslipidemia in the piperine arm.

Evidence strength: Preliminary clinical evidence from one small randomized controlled trial. Larger, well-powered trials are needed to confirm these findings.

5.3 Metabolic Syndrome, Lipid Profile, and Glycemic Control

Findings summarize evidence supporting the beneficial effects of black pepper (Piper nigrum L.), including its active ingredient piperine, in improving blood lipid profiles, including reducing circulating levels of total cholesterol and low-density lipoprotein.

A comprehensive review of curcumin-piperine co-supplementation showed beneficial effects in improving glycemic indices, lipid profile, and antioxidant status in diabetes, improving the inflammatory status caused by obesity and metabolic syndrome, and reducing oxidative stress and depression in chronic stress and neurological disorders. These effects were observed in the context of the combined formulation, making it difficult to attribute outcomes to piperine alone.

Antidiabetic activity has been confirmed in vivo, as well as hypolipidemic activity as evidenced by decrease in the level of cholesterol, triglycerides, and low-density lipoprotein and increase in high-density lipoprotein. The majority of these findings come from animal and in vitro studies.

Evidence strength: Preclinical (animal/in vitro) evidence is reasonably consistent; human clinical trial data, particularly for piperine alone rather than piperine + curcumin, are limited and preliminary.

5.4 Anti-Inflammatory and Analgesic Effects

The anti-inflammatory activity of piperine was tested on interleukin 1β (IL1β)-stimulated fibroblast-like synoviocytes derived from patients with rheumatoid arthritis. The levels of IL6, matrix metalloproteinase (MMPs), cyclooxygenase-2 (COX-2), and prostaglandin E2 (PGE2) were investigated. The analgesic and antiarthritic activities of piperine were investigated on rat models of carrageenan-induced acute paw pain and arthritis, evaluated with a paw pressure test and by measuring squeaking score, paw volume, and weight distribution ratio. Piperine was administered orally to rats at 20 and 100 mg/kg/day for 8 days.

Piper nigrum also has anti-inflammatory, analgesic, anticonvulsant, and neuroprotective effects. These findings are predominantly from preclinical models.

Evidence strength: Convincing preclinical (in vitro and animal model) evidence. Human clinical trials specifically evaluating piperine's anti-inflammatory effects as a standalone agent are sparse.

5.5 Anticancer / Antiproliferative Activity

Piper nigrum exhibited anticancer effects against a number of cell lines from breast, colon, cervical, and prostate through different mechanisms including cytotoxicity, apoptosis, autophagy, and interference with signaling pathways.

Piperine contains various bioactive effects, including immunomodulatory, hepatoprotective, antioxidant, antimetastatic, and anticancer properties that have been established. Clinical trials revealed that this phytochemical has exceptional antioxidant, anticancer, and drug availability-enhancing properties, as well as immunomodulatory potential.

The free-radical scavenging activity of black pepper and its active ingredients might be helpful in chemoprevention and controlling the progression of tumor growth.

Evidence strength: Almost entirely in vitro (cell line) and animal data. Human clinical trial data specifically on piperine as an anticancer agent are absent or extremely limited. Piperine's role in enhancing the bioavailability of chemotherapy drugs has been raised conceptually.

5.6 Neuroprotective Effects and Cognitive Function

Black pepper's major bioactive neuroprotective compounds, such as piperine, may effectively prevent neurodegenerative symptoms and pathological conditions by modulating cell survival signaling and death.

The key alkaloid components of Piper nigrum, that is, piperine, assist in cognitive brain functioning, boost nutrient absorption, and improve gastrointestinal functionality.

Piperine provides therapeutic benefits in patients suffering from Parkinson's disease, Alzheimer's disease, and cerebral stroke, among other neurological conditions. This is stated as a summary of available evidence in a review that covers both preclinical and limited clinical data.

Evidence strength: Primarily preclinical (animal model) evidence. Human clinical studies on piperine's neuroprotective or cognitive effects are limited and not yet conclusive.

5.7 Antimicrobial Activity

Black pepper essential oil has several biological roles, including antioxidant, anti-inflammatory, anticancer, anti-obesity, antidepressant, antidiabetic, antimicrobial, gastroprotective, and insecticidal activities.

Piperine displays numerous pharmacological effects such as antiproliferative, antitumor, antiangiogenesis, antioxidant, antidiabetic, anti-obesity, cardioprotective, antimicrobial, antiaging, and immunomodulatory effects in various in vitro and in vivo experimental trials.

Evidence strength: In vitro (laboratory-based) antimicrobial data exist. Clinical evidence in humans is absent, and therefore antimicrobial uses in humans remain unsupported by clinical trials.

5.8 Gastrointestinal Effects

Piperine stimulates the digestive enzymes of the pancreas, protects against oxidative damage, lowers lipid peroxidation, and enhances the bioavailability of a number of therapeutic drugs.

In human studies, piperine has demonstrated a variety of pharmacological effects, such as gastrointestinal stimulation, anti-asthmatic, antioxidant, anti-hyperlipidemic, anti-diabetic, and anti-inflammatory activities, and enhancement of food absorption.

Evidence strength: Gastrointestinal stimulatory effects are reasonably supported by mechanistic and some clinical data, particularly in the context of enzyme stimulation and food absorption. Specific clinical trials targeting gastrointestinal disease endpoints with piperine as the sole intervention are limited.

5.9 Overall Assessment of Human Evidence

The aforementioned health-promoting benefits associated with black pepper are proven primarily in animal modeling. Thus, there is a need to conduct controlled randomized trials in human subjects, cohort studies, and meta-analyses. This candid assessment from a comprehensive review published in a peer-reviewed journal accurately reflects the current state of the literature: the bioavailability-enhancing effects of piperine in humans are well-established, while most other therapeutic claims rest heavily on preclinical evidence.

6. Body Systems and Health Areas

• Digestive system: Traditionally used for stomachache, dysentery, and digestive disorders. Piperine stimulates pancreatic digestive enzymes and gastrointestinal motility in preclinical models.
• Hepatic system: Piperine exerts anti-oxidative, anti-inflammatory, antihypertensive, neuroprotective, and hepatoprotective effects. Preliminary clinical evidence for NAFLD exists.
• Metabolic and endocrine systems: Antidiabetic property confirmed in vivo as well as hypolipidemic activity, evidenced by decrease in cholesterol, triglycerides, and LDL, and increase in HDL.
• Cardiovascular system: Piperine possesses anti-inflammatory properties through inhibition of COX-2 and has been reported to inhibit platelet aggregation in vitro.
• Respiratory system: Traditionally used for cough, cold, dyspnea, and throat diseases.
• Neurological system: Piper nigrum has anticonvulsant and neuroprotective effects in preclinical models.
• Pharmacokinetic system (bioavailability): Piperine has the ability to alter drug-metabolizing enzymes and bioavailability of several drugs. This is the most clinically documented area.

7. Dosage Forms and Reported Dosages

The average piperine content in pepper is commonly assumed to be 6% by dry weight, and the daily consumption of pepper ranges from approximately 83 to 333 mg. Consequently, doses of 5 to 20 mg of piperine are often administered daily in clinical trials.

Based on black pepper imports, it is estimated that the average consumption of black pepper in the United States is about 359 mg/person/day, which translates to 18.0–32.3 mg of piperine/person/day.

Regulatory and research dosage benchmarks include:

• The Canadian authority Health Canada has elaborated a monograph on the use of Piper nigrum as an ingredient in Natural Health Products. For adults (≥18 years), a daily dose of 250–420 mg for the unextracted powder of Piper nigrum fruits and a daily maximum dose of 14 mg for the use of piperine as an isolated substance in these products were established.
• The recommended dose of piperine for a healthy individual for oral use as a bioavailability enhancer is approximately 5 mg/person/day. The recommended dose in cases of clinically diagnosed nutritional deficiencies is up to 15 mg/person/day in divided doses (5 mg every six hours).
• The bioenhancing dose of piperine is a maximum of approximately 15 mg/person/day, or no more than 20 mg/day.
• In the NAFLD clinical trial: patients were prescribed 5 mg of piperine for 12 weeks.
• In drug interaction studies: human studies with repeated piperine administrations used piperine-only run-in phases of 3–10 days and piperine doses of 15–20 mg/day.

8. Safety Considerations and Drug Interactions

8.1 General Safety Status

Black pepper contains approximately 5–9% piperine and is listed by the FDA as an herb which is generally recognized as safe (GRAS) for its intended use as spice, seasoning, or flavoring. However, the safety profile of piperine as an isolated supplement at bolus doses has received specific regulatory and scientific scrutiny.

Although available human studies rarely reported effects that were regarded as adverse, their suitability for detailed risk assessment is limited due to an insufficient focus on safety parameters apart from drug interactions, as well as due to the lack of investigation of the potentially adverse effects observed in animal studies and/or combined administration of piperine with other substances.

8.2 Drug–Drug and Food–Drug Interactions

Piperine's inhibitory effects on drug-metabolizing enzymes create a meaningful risk of pharmacokinetic interactions with co-administered medications. Clinical studies suggest that piperine (usually in doses of 20 mg/day) can inhibit CYP3A4, CYP2C9, and PGP, resulting in moderate increases in plasma concentrations of CYP3A4 substrates (carbamazepine, midazolam), CYP2C9 substrates (diclofenac, phenytoin, and possibly warfarin), and PGP substrates (fexofenadine and possibly digoxin).

Piperine is found in a number of herbal products, but it is not clear whether dietary use of black pepper would result in clinically significant drug interactions. Individuals who regularly use large amounts of black pepper in their diet should at least consider the possibility of such interactions because heavy users may reach a similar amount of piperine as used in the drug interaction studies.

By enhancing bioavailability, piperine can reduce the required dosage, lower drug costs, minimize the occurrence of drug resistance, and mitigate dose-dependent side effects associated with various medications such as ciprofloxacin, ampicillin, metronidazole, carbamazepine, curcumin, and oxytetracycline.

However, a limited number of published studies have indicated a reduction in bioavailability following oral administration of isoniazid, puerarin, diltiazem, desacetyldiltiazem, and magnolol in combination with piperine or pepper/trikatu (containing piperine majorly). This bidirectional nature of interactions — enhancement for some compounds, reduction for others — underscores the complexity of piperine's pharmacokinetic effects.

In human and animal studies with single or short-term bolus application of isolated piperine, interactions with several drugs, in most cases resulting in increased drug bioavailability, were observed. Depending on the drug and extent of the interaction, such interactions may carry the risk of unintended deleteriously increased or adverse drug effects.

Preliminary evidence suggests that piperine also increases serum concentrations of chlorzoxazone, propranolol, and theophylline.

8.3 Reproductive and Developmental Toxicity

Animal studies with higher daily piperine bolus doses than those used in human interaction studies provide indications of disturbance of spermatogenesis and of maternal reproductive and embryotoxic effects. Black pepper is likely unsafe when taken by mouth in large amounts during pregnancy. These findings from animal studies have not been directly replicated in human subjects, but their existence warrants caution.

8.4 Isolated Piperine vs. Dietary Black Pepper

A key regulatory and safety distinction exists between dietary black pepper as a food spice and isolated piperine ingested in supplement form. Compared to the use of pepper for food seasoning, piperine is used in food supplements in an isolated, concentrated form and ingested as a bolus. Safety reviews have focused specifically on the critical health effects of isolated piperine as a single ingredient in food supplements.

Assuming an average piperine content in pepper of 4–6%, the estimated mean per capita intake by the male population corresponds to 24–36 mg piperine/day, with an estimated intake at the 95th percentile of 64–96 mg piperine/day from dietary sources alone. These dietary intake estimates are relevant context for comparing food-level versus supplemental piperine exposure.

References

• Piper nigrum L.: A Systematic Review of its Botanical Characteristics, Phytochemistry, and Pharmacological Activities — Journal of Natural Remedies (2025)
• Phytochemistry and therapeutic potential of black pepper [Piper nigrum (L.)] essential oil and piperine: a review — Clinical Phytoscience, Springer (2021)
• Anticancer Potential of the Principal Constituent of Piper nigrum, Piperine: A Comprehensive Review — PMC (2024)
• A systematic review on black pepper (Piper nigrum L.): from folk uses to pharmacological applications — PubMed (2019)
• Identification and characterization of piperine synthase from black pepper, Piper nigrum L. — PMC / Communications Biology (2021)
• Predicting Food–Drug Interactions between Piperine and CYP3A4 Substrate Drugs Using PBPK Modeling — PMC / MDPI (2024)
• Bioactive Properties, Bioavailability Profiles, and Clinical Evidence of the Potential Benefits of Black Pepper and Red Pepper against Diverse Metabolic Complications — PMC (2023)
• The impact of piperine on the metabolic conditions of patients with NAFLD and early cirrhosis: a randomized double-blind controlled trial — Scientific Reports (2024)
• Anti-inflammatory and antiarthritic effects of piperine in human IL-1β-stimulated fibroblast-like synoviocytes and rat arthritis models — PMC (2009)
• Black pepper and health claims: a comprehensive treatise — PubMed / Critical Reviews in Food Science and Nutrition (2013)
• Molecular and pharmacological aspects of piperine as a potential molecule for disease prevention and management: evidence from clinical trials — PMC / Beni-Suef University Journal (2022)
• Safety Aspects of the Use of Isolated Piperine Ingested as a Bolus — PMC / Nutrients (2021)
• Safety Aspects of the Use of Isolated Piperine Ingested as a Bolus — PubMed (2021)
• Piperine Drug Interactions — Pharmacy Times
• Piperine Alters the Pharmacokinetics and Anticoagulation of Warfarin in Rats — PMC (2020)
• Effect of a herbal extract containing curcumin and piperine on midazolam, flurbiprofen and paracetamol pharmacokinetics in healthy volunteers — British Journal of Clinical Pharmacology (2013)
• Volatiles of Black Pepper Fruits (Piper nigrum L.) — PMC (2020)
• Effect of storage on the essential oil composition of Piper nigrum L. fruits of different ripening states — PubMed / Journal of Agricultural and Food Chemistry (2004)
• Black Pepper — Chemical Composition and Biological Activities — Advanced Technologies (2021)
• Curcumin-piperine co-supplementation and human health: A comprehensive review — Phytotherapy Research (2023)
• Piperine Inhibits the Activities of Platelet Cytosolic Phospholipase A2 and Thromboxane A2 Synthase — PMC (2014)
• Piperine — A Major Principle of Black Pepper: A Review of Its Bioactivity and Studies — Applied Sciences / MDPI (2019)
• Piperine, Black Pepper — Restorative Medicine Reference Document
• Neuroprotective Effects of Black Pepper and Its Bioactive Compounds — Aging and Disease
• Black Pepper (Maricha) in Ayurveda: Benefits, Uses & Healing Properties — Ask Ayurveda
• Piperine — Wikipedia (for chemical and taxonomic reference)
• Molecular and pharmacological aspects of piperine as a potential molecule for disease prevention and management — Beni-Suef University Journal of Basic and Applied Sciences / Springer (2022)
• Pharmacokinetic Drug Interactions of Piperine: A Review of Pre-clinical and Clinical Studies — PubMed (2024)